NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine - https://archive.org/web/.

Tags: aspirin

5/17/2017

‘Baby aspirin may reduce risk of breast cancer,’ says Washington Post, omitting some major limitations of the study

4/5/2017

CNN claims aspirin can reduce cancer death risk, falling into observational study trap

4/13/2016

Aspirin report from CBS doesn’t go much beyond the news release

4/13/2016

An array of sources make this STAT story on aspirin task force recommendations very strong

9/20/2015

Strong overall, NPR report on aspirin for heart protection would have benefited from more numbers

1 8/27/2015

Harms, limitations explored in Reuters Health’s aspirin/colon cancer coverage

2 8/23/2015

Reader question on OTC pain relievers generates thorough, evidence-based response

4/22/2015

Aspirin for cancer prevention: A few small details would make a big difference in this story

8/13/2012

Can daily aspirin help ward off cancer?

8/13/2012

Daily Aspirin May Reduce Risk of Cancer Death

Story Reviews

Systematic, Criteria-Driven

@HealthNewsRevu

HealthNewsRevuHealthNewsReview.org@HealthNewsRevu·

.@TranspariMED criticizes STAT op-ed for not disclosing pharma funding of author’s institute - similar to criticism we’ve made of STAT op-eds in the past. @transparify @ThinkTankWatch @icer_review https://www.healthnewsreview.org/2021/02/transparency-watchdog-criticizes-stats-non-disclosure-on-pro-pharma-op-ed/

Reply on Twitter 1360214949704982532Retweet on Twitter 13602149497049825323Like on Twitter 13602149497049825328Twitter 1360214949704982532
Retweet on TwitterHealthNewsReview.org Retweeted
ContentScienceContent Science@ContentScience·

If you’re covering COVID-19, you need a robust understanding of how to report on health and science news (and when you're in over your head). Get a leg up with these insights from @garyschwitzer.

https://review.content-science.com/health-and-science-communication-in-the-covid-era-a-qa-with-the-publisher-of-health-news-review/

Reply on Twitter 1359955873561518085Retweet on Twitter 13599558735615180852Like on Twitter 13599558735615180851Twitter 1359955873561518085
HealthNewsRevuHealthNewsReview.org@HealthNewsRevu·

Tech sites @MacRumors & @TechCrunch hype #AppleWatch’s ability to predict #COVID19 without providing the evidence. @mtmdphd was keen observer. https://www.healthnewsreview.org/2021/02/tech-sites-hype-apple-watch-for-covid-19-prediction-without-providing-the-evidence/

Reply on Twitter 1359860468135964683Retweet on Twitter 13598604681359646832Like on Twitter 13598604681359646834Twitter 1359860468135964683
View More

Categories

View More

Tags